Last Updated: 17/11/2024

Functional characterization of the main integral protein components of the parasite-host cell interface of Plasmodium falciparum blood stages

Objectives

The goal of this project is to unravel the functions of major integral components of the parasitophorous vacuolar membrane (PVM), particularly EXP1 and ETRAMP proteins, which are critical for Plasmodium falciparum survival and its interaction with host red blood cells. By using conditional knockout technology and a modified proximity biotinylation method, the project aims to functionally analyze these proteins, identify their interaction partners, and generate a proteome of the PVM’s host-facing side. 

Principal Investigators / Focal Persons

Tobias Spielmann

Rationale and Abstract

The intracellular development of the human malaria parasite Plasmodium falciparum in red blood cells is responsible for the clinical symptoms of malaria. In the red blood cell, the parasite is separated from the host cell cytosol by a membrane called the parasitophorous vacuolar membrane (PVM). This membrane plays a key role in the interaction of the parasite with its host cell but many of its functions are poorly understood or unknown. The PVM contains short, highly charged and highly abundant integral membrane proteins termed EXP1 and ETRAMPs (a family of 14 proteins). These molecules are the only so far known proteins bridging this membrane (they contain a domain reaching into the host cell and one facing the parasite). Several, including EXP1, are indicated to be essential for parasite survival and they likely play critical roles in the interaction of the parasite with the host cell. However, due to technical limitations, they have so far not been functionally analysed in P. falciparum parasites. Using new technology the team generated a conditional knock out of EXP1. This work to unravel the function of the major integral components of the parasite host cell interface and to contribute to an understanding how the parasite exploits and interacts with the host red blood cell.

Date

Jan 2018 — Dec 2022

Funding Details
Project Site

Germany

SHARE
SHARE